Lamprey-derived antibody specifically recognizes human plasma cells

Antibody-secreting plasma cells arise from B cell precursors and are essential for adaptive immune responses against invading pathogens. Plasma cell dysfunction is associated with autoimmune and neoplastic disorders, including multiple myeloma. Surface markers that are specific to plasma cells have not been identified and antibodies that only recognize these cells have been challenging to generate using conventional systems.

In the current issue of JCI Insight, Götz Ehrhardt and colleagues at the University of Toronto describe the generation of a plasma cell-specific antibody from immunized lampreys. The authors injected lamprey larvae with a bone marrow isolate from a patient and screened the resulting for those that recognized both malignant and non-malignant plasma cells.

Further characterization of antibody VLRB MM3 revealed that this antibody is specific to and does not recognize other B cell populations or progenitors. VLRB MM3 binding was shown to coincide with CD38 dimerization and correlate with and impede the NAD glycohydrolase activity of this glycoprotein.

The VLRB MM3 antibody represents a unique tool with potential for both diagnostic and therapeutic applications for plasma cell disorders.

Explore further

Shp1 protein helps immune system develop its long-term memory

More information: Cuiling Yu et al. Identification of human plasma cells with a lamprey monoclonal antibody, JCI Insight (2016). DOI: 10.1172/jci.insight.84738
Citation: Lamprey-derived antibody specifically recognizes human plasma cells (2016, March 17) retrieved 18 June 2021 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments